Chinmay Jani, MD, describes how he counsels patients with and without a smoking history on a lung cancer diagnosis.
|Articles|January 1, 2001
Oncology NEWS International
- Oncology NEWS International Vol 10 No 1
- Volume 10
- Issue 1
California’s Lung Cancer Decline Shows Effectiveness of Tobacco Control
WASHINGTON-California’s aggressive tobacco control efforts, which include raising tobacco taxes and using some of that revenue for prevention efforts, appear to have played a significant role in the state’s decrease in lung cancer rates, according to a new collaborative study released by the Centers for Disease Control and Prevention and the California Department of Health Services.
Advertisement
WASHINGTONCalifornia’s aggressive tobacco control efforts, which include raising tobacco taxes and using some of that revenue for prevention efforts, appear to have played a significant role in the state’s decrease in lung cancer rates, according to a new collaborative study released by the Centers for Disease Control and Prevention and the California Department of Health Services.
The study showed a decline in lung and bronchus cancer incidence from 1988 to 1997 of 14% for California, compared with 2.7% for eight selected regions of the country. The incidence rate decreased 4.8% among California women, while rising 13.2% in the comparison regions. Among California men, the rate of decline was 1.5 times greater than that seen in the other areas studied.
Articles in this issue
almost 26 years ago
ODAC Recommends Campath for FDA Approval for Refractory CLLalmost 26 years ago
‘IrinoGem’ Active and Well Tolerated in Pancreatic Canceralmost 26 years ago
STI571 Studies Help Validate Molecular Targeting in CMLalmost 26 years ago
Outpatient Mylotarg Therapy Cuts Costs in Relapsed AMLalmost 26 years ago
STI571 Proves Effective in Patients With Interferon-Failure CMLalmost 26 years ago
Prostate Cancer Patients Tolerate Higher 3D Conformal RT Dosesalmost 26 years ago
IP6 (Phytic Acid) Inhibits Breast Cancer in Animalsalmost 26 years ago
Adjuvant Therapy Beneficial in Early, Node-Negative Breast Canceralmost 26 years ago
Medicare Increases Payment Rates for Most Physiciansalmost 26 years ago
Update on High-Dose Consolidation Therapy in Breast CancerAdvertisement
Related to this article
Chinmay Jani, MD, discusses ASCO 2026 data on lung cancer trends in younger adults and why this group has been overlooked.
Chinmay Jani, MD, explains how air pollution and asbestos contribute to lung cancer deaths beyond tobacco.
Chinmay Jani, MD, highlights non-smoking risk factors, the impact of lung cancer on younger populations, and the value of comprehensive molecular testing.
Dwight H. Owen, MBBCh, MS, discussed why severe immune-related toxicities remain hard to predict as immunotherapy combinations expand in lung cancer.
Presentations at ESMO Congress 2026 detailed how surgery, radiation oncology, and supportive care can contribute to the treatment of patients with NSCLC.
"As we combine more treatments…they have overlapping toxicities, and they may have the ability to synergize in a negative way," said Dwight H. Owen, MBBCh, MS.
Advertisement
Advertisement
Trending on CancerNetwork
1
What Separates a Next-Generation Liver Tumor Board From the Traditional Model?
2
Weighing Immunotherapy for Bridging and Downstaging Before HCC Transplant
3
BOT+BAL Yields Long-Term Survival in Patients With Refractory MSS mCRC
4
MASLD Raises Liver and Other Cancer Risks, Supporting Selective HCC Surveillance
5